IDO1 and neoplasm: Additionally, we treated tumor cells with the ferroptosis activator erastin and observed that erastin significantly increased KYNU expression while suppressing IDO1 expression; in contrast, the ferroptosis inhibitor Ferrostatin-1 produced the opposite result (Figure 4B).